<h4>Background</h4>Diabetes technologies-including continuous glucose monitoring (CGM), insulin pumps, and hybrid closed-loop systems-have profoundly transformed self-management in type 1 diabetes (T1D). This evidence concerns the gene INS and diabetes mellitus.